Abstract Background A major challenge in the interpretation of genomic profiling data generated from breast cancer samples is the identification of driver genes as distinct from bystander genes which do not impact tumorigenesis. One way to assess the relative importance of alterations in the transcriptome profile is to combine parallel analyses that assess changes in the copy number alterations (CNAs). This integrated analysis permits the identification of genes with altered expression that map within specific chromosomal regions which demonstrate copy number alterations, providing a mechanistic approach to identify the 'driver genes'. Methods We have performed whole genome analysis of CNAs using the Affymetrix 250K Mapping array on 22 infi...
Abstract Background Clear cell renal carcinoma (RCC) is the most common and invasive adult renal can...
The elucidation of breast cancer subgroups and their molecular drivers requires integrated views of ...
The elucidation of breast cancer subgroups and their molecular drivers requires integrated views of ...
Genomic copy number alterations are common in cancer. Finding the genes causally implicated in oncog...
Thesis (Ph.D.)--Boston University PLEASE NOTE: Boston University Libraries did not receive an Autho...
<div><p>Genomic copy number alterations are common in cancer. Finding the genes causally implicated ...
Breast cancer is a heterogeneous disease, marked by extensive chromosomal aberrations. In this study...
In the era of precision medicine, analyzing the transcriptomic profile of patients is essential to t...
International audienceChromosome 1 is involved in quantitative anomalies in 50-60% of breast tumours...
International audienceChromosome 1 is involved in quantitative anomalies in 50-60% of breast tumours...
Loss of heterozygosity (LOH) of chromosome 16q24.3 is a common genetic alteration observed in invasi...
<div><p>Integrative analyses of multiple genomic datasets for selected samples can provide better in...
International audienceChromosome 1 is involved in quantitative anomalies in 50-60% of breast tumours...
Integrative analyses of multiple genomic datasets for selected samples can provide better insight in...
Abstract: Background: Clear cell renal carcinoma (RCC) is the most common and invasive adult renal c...
Abstract Background Clear cell renal carcinoma (RCC) is the most common and invasive adult renal can...
The elucidation of breast cancer subgroups and their molecular drivers requires integrated views of ...
The elucidation of breast cancer subgroups and their molecular drivers requires integrated views of ...
Genomic copy number alterations are common in cancer. Finding the genes causally implicated in oncog...
Thesis (Ph.D.)--Boston University PLEASE NOTE: Boston University Libraries did not receive an Autho...
<div><p>Genomic copy number alterations are common in cancer. Finding the genes causally implicated ...
Breast cancer is a heterogeneous disease, marked by extensive chromosomal aberrations. In this study...
In the era of precision medicine, analyzing the transcriptomic profile of patients is essential to t...
International audienceChromosome 1 is involved in quantitative anomalies in 50-60% of breast tumours...
International audienceChromosome 1 is involved in quantitative anomalies in 50-60% of breast tumours...
Loss of heterozygosity (LOH) of chromosome 16q24.3 is a common genetic alteration observed in invasi...
<div><p>Integrative analyses of multiple genomic datasets for selected samples can provide better in...
International audienceChromosome 1 is involved in quantitative anomalies in 50-60% of breast tumours...
Integrative analyses of multiple genomic datasets for selected samples can provide better insight in...
Abstract: Background: Clear cell renal carcinoma (RCC) is the most common and invasive adult renal c...
Abstract Background Clear cell renal carcinoma (RCC) is the most common and invasive adult renal can...
The elucidation of breast cancer subgroups and their molecular drivers requires integrated views of ...
The elucidation of breast cancer subgroups and their molecular drivers requires integrated views of ...